title: Sustaining high acetylcholine levels in the frontal cortex, but not retrosplenial cortex, recovers spatial memory performance in a rodent model of diencephalic amnesia.
abstract: Although the thalamus and/or mammillary bodies are the primary sites of neuropathology in cases of diencephalic amnesia such as Wernicke Korsakoff Syndrome (WKS), there is also functional deactivation of certain cortical regions that contribute to the cognitive dysfunction. Acetylcholine (ACh) is a key neurotransmitter that modulates neural processing within the cortex and between the thalamus and cortex. In the pyrithiamine-induced thiamine deficiency (PTD) rat model of WKS, there are significant reductions in cholinergic innervation and behaviorally stimulated ACh efflux in the frontal (FC) and retrosplenial (RSC) cortices. In the present study, ACh released levels were site-specifically amplified with physostigmine (0.5 μg, 1.0 μg) in the FC and the RSC, which was confirmed with in vivo microdialysis. Although physostigmine sustained high ACh levels in both cortical regions, the effects on spatial memory, assessed by spontaneous alternation, were different as a function of region (FC, RSC) and treatment (PTD, pair-fed [PF]). Higher ACh levels in the FC recovered the rate of alternation in PTD rats as well as reduced arm-reentry perseverative errors. However, higher ACh levels within the FC of PF rats exacerbated arm-reentry perseverative errors without significantly affecting alternation rates. Maintaining high ACh levels in the RSC had no procognitive effects in PTD rats, but rather impaired alternation behavior in PF rats. These results demonstrate that diverse cortical regions respond differently to intensified ACh levels-and the effects are dependent on thalamic pathology. Thus, pharmacotherapeutics aimed at enhancing cognitive functions must account for the unique features of cortical ACh stimulation and the connective circuitry with the thalamus.
authors.affiliation: Behavioral Neuroscience Program, Department of Psychology, State University of New York at Binghamton, Binghamton, NY 13902, USA. lsavage@binghamton.edu
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Savage
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D005625:Frontal Lobe / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D006179:Gyrus Cinguli / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D006624:Hippocampus / Q000187:drug effects; D020915:Korsakoff Syndrome / Q000378:metabolism / Q000503:physiopathology*; D018782:Maze Learning / Q000187:drug effects; D017551:Microdialysis; D023421:Models, Animal; D010830:Physostigmine; D011745:Pyrithiamine; D051381:Rats; D013788:Thalamus / Q000187:drug effects / Q000473:pathology; D013832:Thiamine Deficiency / Q000139:chemically induced
chemical_list: D011745:Pyrithiamine; D010830:Physostigmine; D000109:Acetylcholine